Geode Capital Management’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-130,774
| Closed | -$10K | – | 4948 |
|
|
2022
Q4 | $10K | Hold |
130,774
| – | – | ﹤0.01% | 4844 |
|
|
2022
Q3 | $16K | Hold |
130,774
| – | – | ﹤0.01% | 4942 |
|
|
2022
Q2 | $37K | Hold |
130,774
| – | – | ﹤0.01% | 4843 |
|
|
2022
Q1 | $41K | Hold |
130,774
| – | – | ﹤0.01% | 4844 |
|
|
2021
Q4 | $300K | Buy |
130,774
+53,078
| +68% | +$157K | ﹤0.01% | 4293 |
|
|
2021
Q3 | $179K | Buy |
77,696
+14,474
| +23% | +$54.8K | ﹤0.01% | 4495 |
|
|
2021
Q2 | $345K | Buy |
63,222
+18,748
| +42% | +$101K | ﹤0.01% | 4103 |
|
|
2021
Q1 | $233K | Buy |
44,474
+26,876
| +153% | +$147K | ﹤0.01% | 4067 |
|
|
2020
Q4 | $60K | Hold |
17,598
| – | – | ﹤0.01% | 4138 |
|
|
2020
Q3 | $34K | Hold |
17,598
| – | – | ﹤0.01% | 4072 |
|
|
2020
Q2 | $45K | Hold |
17,598
| – | – | ﹤0.01% | 3992 |
|
|
2020
Q1 | $29K | Hold |
17,598
| – | – | ﹤0.01% | 4008 |
|
|
2019
Q4 | $10K | Hold |
17,598
| – | – | ﹤0.01% | 4191 |
|
|
2019
Q3 | $17K | Hold |
17,598
| – | – | ﹤0.01% | 4161 |
|
|
2019
Q2 | $25K | Buy |
17,598
+910
| +5% | +$1.41K | ﹤0.01% | 4149 |
|
|
2019
Q1 | $27K | Hold |
16,688
| – | – | ﹤0.01% | 4074 |
|
|
2018
Q4 | $16K | Hold |
16,688
| – | – | ﹤0.01% | 4111 |
|
|
2018
Q3 | $33K | Hold |
16,688
| – | – | ﹤0.01% | 4064 |
|
|
2018
Q2 | $41K | Hold |
16,688
| – | – | ﹤0.01% | 3992 |
|
|
2018
Q1 | $50K | Hold |
16,688
| – | – | ﹤0.01% | 3952 |
|
|
2017
Q4 | $66K | Hold |
16,688
| – | – | ﹤0.01% | 3888 |
|
|
2017
Q3 | $57K | Hold |
16,688
| – | – | ﹤0.01% | 3915 |
|
|
2017
Q2 | $49K | Hold |
16,688
| – | – | ﹤0.01% | 3966 |
|
|
2017
Q1 | $26K | Hold |
16,688
| – | – | ﹤0.01% | 4026 |
|
|
2016
Q4 | $23K | Hold |
16,688
| – | – | ﹤0.01% | 3993 |
|
|
2016
Q3 | $29K | Hold |
16,688
| – | – | ﹤0.01% | 3971 |
|
|
2016
Q2 | $47K | Hold |
16,688
| – | – | ﹤0.01% | 3937 |
|
|
2016
Q1 | $42 | Hold |
16,688
| – | – | ﹤0.01% | 3992 |
|
|
2015
Q4 | $58K | Buy |
16,688
+4,751
| +40% | +$19.1K | ﹤0.01% | 3982 |
|
|
2015
Q3 | $51K | Buy |
+11,937
| New | +$48.6K | ﹤0.01% | 4009 |
|
|
2015
Q1 | – | Sell |
-6,627
| Closed | -$37K | – | 3977 |
|
|
2014
Q4 | $37K | Hold |
6,627
| – | – | ﹤0.01% | 3909 |
|
|
2014
Q3 | $60K | Hold |
6,627
| – | – | ﹤0.01% | 3816 |
|
|
2014
Q2 | $63K | Hold |
6,627
| – | – | ﹤0.01% | 3750 |
|
|
2014
Q1 | $90K | Hold |
6,627
| – | – | ﹤0.01% | 3679 |
|
|
2013
Q4 | $155K | Sell |
6,627
-35
| -0.5% | -$952 | ﹤0.01% | 3493 |
|
|
2013
Q3 | $208K | Buy |
6,662
+4
| +0.1% | +$132 | ﹤0.01% | 3298 |
|
|
2013
Q2 | $210K | Buy |
+6,658
| New | +$229K | ﹤0.01% | 3219 |
|
Other funds holding STAB
Geode Capital Management's STAB Position: Q1 2023 in Review
Geode Capital Management sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q1 2023, closing a stake of 130,774 shares — an estimated $10K sold.
Geode Capital Management first reported a position in STAB in Q2 2013 and held it in 37 quarters. The position peaked at $345K in Q2 2021. 4 funds tracked by Wall St. Rank hold STAB as of Q1 2023.
- Geode Capital Management reported no remaining Statera Biopharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- Geode Capital Management sold 130,774 Statera Biopharma, Inc. Common Stock shares in Q1 2023, an estimated $10K.
- Geode Capital Management first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and held it in 37 quarters.
- Geode Capital Management's Statera Biopharma, Inc. Common Stock position peaked at $345K in Q2 2021.
- 4 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q1 2023.
Based on Geode Capital Management's 13F filing for Q1 2023, filed 15 May 2023.